Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

Y. Shi; M. Dong; X. Hong; W. Zhang; J. Feng; J. Zhu; L. Yu; X. Ke; H. Huang; Z. Shen; Y. Fan; W. Li; X. Zhao; J. Qi; H. Huang; D. Zhou; Z. Ning; X. Lu

doi:10.1093/annonc/mdv237

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

Annals of Oncology ◽

10.1093/annonc/mdv237 ◽

2015 ◽

Vol 26 (8) ◽

pp. 1766-1771 ◽

Cited By ~ 101

Author(s):

Y. Shi ◽

M. Dong ◽

X. Hong ◽

W. Zhang ◽

J. Feng ◽

...

Keyword(s):

T Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Open Label ◽

Peripheral T Cell Lymphoma ◽

Pivotal Phase

Download Full-text

Faculty Opinions recommendation of Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725585447.793539750 ◽

2017 ◽

Author(s):

Won Seog Kim

Keyword(s):

T Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Open Label ◽

Peripheral T Cell Lymphoma ◽

Pivotal Phase

Download Full-text

PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA

Hematological Oncology ◽

10.1002/hon.2438_115 ◽

2017 ◽

Vol 35 ◽

pp. 251-252 ◽

Cited By ~ 1

Author(s):

T. Witzig ◽

L. Sokol ◽

E. Jacobsen ◽

R. Advani ◽

R. Mondejar ◽

...

Keyword(s):

T Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Open Label ◽

Peripheral T Cell Lymphoma ◽

Preliminary Results ◽

Open Label Phase

Download Full-text

An open-label phase II study of intravenous bortezomib and oral panobinostat (LBH589) in adult patients with relapsed/refractory peripheral T-cell lymphoma (PTCL) or NK/T-cell lymphoma (NKL) after failure of conventional chemotherapy.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.tps224 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. TPS224-TPS224

Author(s):

D. C. Tan ◽

P. Chan ◽

B. L. Ng ◽

B. K. Yap ◽

Y. H. Chan ◽

...

Keyword(s):

T Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Adult Patients ◽

Conventional Chemotherapy ◽

Open Label ◽

Peripheral T Cell Lymphoma ◽

Open Label Phase

Download Full-text

Faculty Opinions recommendation of Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264183.15777338 ◽

2012 ◽

Author(s):

Nicolas Mounier

Keyword(s):

T Cell ◽

Phase Ii ◽

Systemic Therapy ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Open Label ◽

Peripheral T Cell Lymphoma ◽

Open Label Phase ◽

Prior Systemic Therapy

Download Full-text

A PHASE II STUDY OF ANTI‐PD‐1 SINTILIMAB IN COMBINATION WITH CHIDAMIDE AND AZACITIDINE IN REFRACTORY AND RELAPSED PERIPHERAL T‐CELL LYMPHOMA

Hematological Oncology ◽

10.1002/hon.168_2880 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

Z. Ying ◽

Y. Song ◽

X. Wang ◽

N. Lin ◽

Y. Xie ◽

...

Keyword(s):

T Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Peripheral T Cell Lymphoma

Download Full-text

TELLOMAK: T-CELL LYMPHOMA ANTI-KIR3DL2 THERAPY: AN OPEN LABEL, MULTI-COHORT, MULTI-CENTER, INTERNATIONAL PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF IPH4102 ALONE OR IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH ADVANCED T-CELL LYMPHOMA

Hematological Oncology ◽

10.1002/hon.40_2629 ◽

2019 ◽

Vol 37 ◽

pp. 72-73

Author(s):

P. Porcu ◽

Y. Kim ◽

P. Zinzani ◽

H. Sicard ◽

H.A. Azim ◽

...

Keyword(s):

T Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Efficacy And Safety ◽

Open Label

Download Full-text

Phase II study of the irinotecan (CPT-11), mitoxantrone and dexamethasone regimen in elderly patients with relapsed or refractory peripheral T-cell lymphoma

Cancer Science ◽

10.1111/j.1349-7006.2006.00349.x ◽

2007 ◽

Vol 98 (1) ◽

pp. 109-112 ◽

Cited By ~ 6

Author(s):

Nozomi Niitsu ◽

Mika Kohori ◽

Masaaki Higashihara ◽

Masami Bessho

Keyword(s):

T Cell ◽

Elderly Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Peripheral T Cell Lymphoma

Download Full-text

Complete responses (CR/CRu) on a phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.8033 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 8033-8033 ◽

Cited By ~ 3

Author(s):

S. M. Horwitz ◽

B. Coiffier ◽

F. M. Foss ◽

H. M. Prince ◽

L. Sokol ◽

...

Keyword(s):

T Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Peripheral T Cell Lymphoma

Download Full-text

A multicenter, open label, phase II study to assess the efficacy and safety of APO866 in the treatment of patients with refractory or relapsed cutaneous T-cell lymphoma.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e20044 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e20044-e20044

Author(s):

Simone M. Goldinger ◽

Sharon Gobbi ◽

Michelle Ding ◽

Anna Lisa Frauchiger ◽

Regina Fink-Puches ◽

...

Keyword(s):

T Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Cutaneous T Cell Lymphoma ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Phase

Download Full-text

Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901

Leukemia & Lymphoma ◽

10.1080/10428190600961058 ◽

2007 ◽

Vol 48 (1) ◽

pp. 97-103 ◽

Cited By ~ 30

Author(s):

Myron S. Czuczman ◽

Pierluigi Porcu ◽

Jeffrey Johnson ◽

Donna Niedzwiecki ◽

Michael Kelly ◽

...

Keyword(s):

T Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Cutaneous T Cell Lymphoma ◽

Peripheral T Cell Lymphoma

Download Full-text